KOBLISH ANTONY 4
4 · TELA Bio, Inc. · Filed Feb 25, 2025
Insider Transaction Report
Form 4
TELA Bio, Inc.TELA
KOBLISH ANTONY
DirectorChief Executive Officer
Transactions
- Tax Payment
Common Stock
2025-02-24$2.65/sh−5,772$15,296→ 590,494 total - Award
Common Stock
2025-02-21+149,000→ 607,897 total - Tax Payment
Common Stock
2025-02-23$2.72/sh−11,631$31,636→ 596,266 total - Award
Stock Option (Right to Buy)
2025-02-21+219,000→ 219,000 totalExercise: $2.72Exp: 2035-02-21→ Common Stock (219,000 underlying)
Footnotes (3)
- [F1]These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 21, 2026, subject to the Reporting Person's continuous service through the applicable vesting dates.
- [F2]Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs.
- [F3]The option vests 25% on February 21, 2026, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.